PS315 T16671
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
PS315 inhibits the full-length and catalytic domain constructs of PKC_ (IC50=10 _M) and PKC_ (IC50=30 _M). PS315 has anti-cancer activity. PS315 is a derivative of PS48 and is an allosteric PKC inhibitor by binding to the PIF-pocket of aPKC and inducing d
CAS nr:
1221964-50-6
Purity:
98%
Molecular Weight:
362,85
SMILES:
O=C(O)/C=C(C1=CC=C(C2=CC=CC=C2)C=C1)/CCC3=CC=C(Cl)C=C3
Formula:
C23H19ClO2
Pathway:
Cytoskeletal Signaling,Chromatin/Epigenetic
Target:
PKC,PKC
